Skip to content

Effect of Vergence Exercises for Patients With Convergence Insufficiency After Concussion.

Effect of Vergence Exercises for Rehabilitation of Patients With Convergence Insufficiency as a Long-term Consequence of Concussion.

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05012384
Enrollment
100
Registered
2021-08-19
Start date
2021-07-01
Completion date
2025-08-01
Last updated
2023-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Concussion, Mild, Convergence Insufficiency

Brief summary

A large proportion of concussion patients with long-term consequences of concussion experience visually related symptoms such as headache, blurred vision, double vision, and fatigue. These patients often have difficulties coordinating the movement of the two eyes (convergence insufficiency) which is essential for single and clear vision to be obtained and is hence a likely explanation for the symptoms. 100 patients with long-term symptoms of concussion and convergence insufficiency will be offered either exercises or placebo treatment the evaluate the effect of exercises aimed at improving coordination between the two eyes. The study will provide data to support clinicians in deciding whether to use exercises or not as a treatment of symptoms for patients with convergence insufficiency as a long-term consequence of concussion.

Interventions

OTHERVergence exercises (Orthoptic exercises)

Vergence exercises as described by the Convergence Insufficiency Treatment Trials Group (CITT)

GENETICPlacebo

Generic management plan with non-visual elements

Sponsors

Danish College of Optometry and Vision Science
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Randomized clinical trial

Eligibility

Sex/Gender
ALL
Age
30 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Concussion at least 3 month ago * Convergence insufficiency which has not been diagnosed prior to the concussion

Exclusion criteria

* Patient who are unable to fulfill baseline examination * Manifest or paralytic strabismus * Self-reported eye disease

Design outcomes

Primary

MeasureTime frameDescription
Vergence facility at 40 cm - week 36Duration (2 minutes) and performed at week 36Psychophysical test of fast fusional adaptation
Positive fusional vergence at 40 cm - week 36Duration (2 minutes) and performed at week 36Psychophysical test of the slow fusional adaptation
Vergence facility at 40 cm - week 18Duration (2 minutes) and performed at week 18Psychophysical test of fast fusional adaptation
Convergence Insufficiency Symptom Survey (CISS) week 18Duration (5 minutes) and performed at week 18Questionnaire assessing the frequency of eye and visually related symptom during near work
Convergence Insufficiency Symptom Survey (CISS) week 36Duration (5 minutes) and performed at week 36Questionnaire assessing the frequency of eye and visually related symptom during near work
Near point of convergence - week 18Duration (2 minutes) and performed at week 18Psychophysical test of the eyes ability to converge
Near point of convergence - week 36Duration (2 minutes) and performed at week 36Psychophysical test of the eyes ability to converge
Positive fusional vergence at 40 cm - week 18Duration (2 minutes) and performed at week 18Psychophysical test of the slow fusional adaptation

Secondary

MeasureTime frameDescription
Rivermead post-concussional symptoms questionnaire (RPQ) - week 36Duration (5 minutes) and performed at week 36Questionnaire assessing the frequency of symptoms during activities of daily living
Rivermead post-concussional symptoms questionnaire (RPQ) - week 18Duration (5 minutes) and performed at week 18Questionnaire assessing the frequency of symptoms during activities of daily living

Countries

Denmark

Contacts

Primary ContactMarianne L Maagaard, MSc
mlm@eadania.dk+45 22 91 92 01
Backup ContactIvan Nisted, MPH
ivn@eadania.dk+45 30 82 57 64

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026